Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.99M | 2.70M | 2.29M | 2.29M | 1.91M |
| Total Other Revenue | -- | -100.00 | -100.00 | -100.00 | -100.00 |
| Total Revenue | 2.99M | 2.70M | 2.29M | 2.29M | 1.91M |
| Cost of Revenue | 1.18M | 1.00M | 934.40K | 948.70K | 970.50K |
| Gross Profit | 1.81M | 1.69M | 1.35M | 1.35M | 935.10K |
| SG&A Expenses | 1.75M | 1.87M | 1.88M | 1.80M | 1.68M |
| Depreciation & Amortization | 6.30K | 6.30K | 6.20K | 6.10K | 6.10K |
| Other Operating Expenses | 94.00K | -181.40K | 68.20K | -86.30K | -31.30K |
| Total Operating Expenses | 3.03M | 2.70M | 2.89M | 2.67M | 2.63M |
| Operating Income | -40.60K | -400.00 | -599.90K | -374.50K | -721.00K |
| Income Before Tax | -29.30K | 12.20K | -599.10K | -378.30K | -718.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.03 | 0.01 | -0.60 | -0.38 | -0.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.30K | 12.20K | -599.10K | -378.30K | -718.60K |
| EBIT | -40.60K | -400.00 | -599.90K | -374.50K | -721.00K |
| EBITDA | -34.30K | 5.90K | -593.70K | -368.50K | -715.00K |
| EPS Basic | 0.00 | 0.00 | -0.04 | -0.03 | -0.05 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.03 | -0.02 | -0.03 |
| EPS Diluted | 0.00 | 0.00 | -0.04 | -0.03 | -0.05 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.03 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 65.22M | 62.52M | 59.54M | 57.49M | 55.99M |
| Average Diluted Shares Outstanding | 65.22M | 62.52M | 59.54M | 57.49M | 55.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |